Literature DB >> 22522791

Evidence for a protective role of the STAT5 transcription factor against oxidative stress in human leukemic pre-B cells.

E Cholez1, V Debuysscher, J Bourgeais, C Boudot, J Leprince, F Tron, B Brassart, A Regnier, E Bissac, E Pecnard, F Gouilleux, K Lassoued, V Gouilleux-Gruart.   

Abstract

STAT5 transcription factors are involved in normal B lymphocyte development and in leukemogenesis. We show that the inhibition of STAT5A expression or activity in the NALM6, 697 and Reh leukemic pre-B cell lines, results in a higher spontaneous apoptosis and an increased FAS-induced cell death. However, the molecular mechanisms underlying the altered pre-B cell survival are unclear. We used a proteomic approach to identify proteins that are differentially regulated in cells expressing (NALM6Δ5A) or not a dominant negative form of STAT5A. Among the 14 proteins identified, six were involved in the control of the oxidative stress like glutathione (GSH) synthetase and DJ-1. Accordingly, we showed increased levels of reactive oxygen species (ROS) in NALM6Δ5A cells and suppression of the increased sensitivity to Fas-mediated apoptosis by the GSH tripeptide. Similar results were observed when NALM6 cells were treated with TAT-STAT5Δ5A fusion proteins or STAT5A shRNA. In addition, the 697 and Reh pre-B cells were found to share number of molecular changes observed in NALM6Δ5A cells including ROS generation, following inhibition of STAT5 expression or function. Our results point out to a hitherto undescribed link between STAT5 and oxidative stress and provide new insights into STAT5 functions and their roles in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22522791     DOI: 10.1038/leu.2012.112

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  13 in total

1.  Antioxidation improves in puberty in normal weight and obese boys, in positive association with exercise-stimulated growth hormone secretion.

Authors:  George Paltoglou; Ioannis G Fatouros; George Valsamakis; Maria Schoina; Alexandra Avloniti; Athanasios Chatzinikolaou; Antonis Kambas; Dimitris Draganidis; Aimilia Mantzou; Maria Papagianni; Christina Kanaka-Gantenbein; George P Chrousos; George Mastorakos
Journal:  Pediatr Res       Date:  2015-05-04       Impact factor: 3.756

2.  Interrelations among the adipocytokines leptin and adiponectin, oxidative stress and aseptic inflammation markers in pre- and early-pubertal normal-weight and obese boys.

Authors:  George Paltoglou; Maria Schoina; George Valsamakis; Nicolaos Salakos; Alexandra Avloniti; Athanasios Chatzinikolaou; Alexandra Margeli; Chrysanthi Skevaki; Maria Papagianni; Christina Kanaka-Gantenbein; Ioannis Papassotiriou; George P Chrousos; Ioannis G Fatouros; George Mastorakos
Journal:  Endocrine       Date:  2017-01-16       Impact factor: 3.633

3.  High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells.

Authors:  Veronika Kanderova; Daniela Kuzilkova; Jan Stuchly; Martina Vaskova; Tomas Brdicka; Karel Fiser; Ondrej Hrusak; Fridtjof Lund-Johansen; Tomas Kalina
Journal:  Mol Cell Proteomics       Date:  2016-01-19       Impact factor: 5.911

Review 4.  Oxidative metabolism in cancer: A STAT affair?

Authors:  Jérome Bourgeais; Valérie Gouilleux-Gruart; Fabrice Gouilleux
Journal:  JAKSTAT       Date:  2013-08-12

5.  Src family kinases interfere with dimerization of STAT5A through a phosphotyrosine-SH2 domain interaction.

Authors:  Dirk Fahrenkamp; Hildegard Schmitz-Van de Leur; Andrea Küster; Nicolas Chatain; Gerhard Müller-Newen
Journal:  Cell Commun Signal       Date:  2015-02-15       Impact factor: 5.712

Review 6.  Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.

Authors:  Anna Orlova; Bettina Wingelhofer; Heidi A Neubauer; Barbara Maurer; Angelika Berger-Becvar; György Miklós Keserű; Patrick T Gunning; Peter Valent; Richard Moriggl
Journal:  Expert Opin Ther Targets       Date:  2017-11-24       Impact factor: 6.902

Review 7.  Exercise-Induced Oxidative Stress Responses in the Pediatric Population.

Authors:  Alexandra Avloniti; Athanasios Chatzinikolaou; Chariklia K Deli; Dimitris Vlachopoulos; Luis Gracia-Marco; Diamanda Leontsini; Dimitrios Draganidis; Athanasios Z Jamurtas; George Mastorakos; Ioannis G Fatouros
Journal:  Antioxidants (Basel)       Date:  2017-01-17

Review 8.  Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression.

Authors:  Wook Jin
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

9.  Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia.

Authors:  Maike Buchner; Eugene Park; Huimin Geng; Lars Klemm; Johanna Flach; Emmanuelle Passegué; Hilde Schjerven; Ari Melnick; Elisabeth Paietta; Dragana Kopanja; Pradip Raychaudhuri; Markus Müschen
Journal:  Nat Commun       Date:  2015-03-10       Impact factor: 14.919

10.  Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses.

Authors:  Jerome Bourgeais; Nicole Ishac; Magdalena Medrzycki; Marie Brachet-Botineau; Laura Desbourdes; Valerie Gouilleux-Gruart; Emmanuel Pecnard; Florence Rouleux-Bonnin; Emmanuel Gyan; Jorge Domenech; Frederic Mazurier; Richard Moriggl; Kevin D Bunting; Olivier Herault; Fabrice Gouilleux
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.